XML 91 R72.htm IDEA: XBRL DOCUMENT v3.23.1
Subsequent Events (Details) - USD ($)
$ in Millions
3 Months Ended 9 Months Ended
Oct. 01, 2022
Mar. 31, 2023
Mar. 31, 2022
Mar. 31, 2021
Mar. 31, 2023
Mar. 31, 2022
Jun. 30, 2023
Dec. 31, 2022
Sep. 30, 2022
Jun. 30, 2022
Dec. 31, 2021
Jun. 30, 2021
Subsequent Event                        
Unrecognized Tax Benefits, Including Income Tax Penalties and Interest Accrued   $ 2.0     $ 2.0         $ 5.0    
Assets   10,830.0     10,830.0   $ 10,508.0 $ 11,148.0 $ 10,206.0 10,508.0    
Line of Credit, Current   715.0     715.0              
Other comprehensive income/(loss) before reclassifications   25.0 $ (6.0)   22.0 $ (35.0)            
Foreign currency translation adjustments   27.0 (22.0)   10.0 (54.0)            
Net change in derivatives and hedges, net of tax   (2.0) 17.0   12.0 21.0            
Available for sale investments   2.0 (1.0)   4.0 (2.0)            
Other Comprehensive Income, Other, Net of Tax   27.0 (5.0)   26.0 (33.0)            
Accumulated other comprehensive income/(loss)   (368.0) (350.0)   (368.0) (350.0)   (395.0)   (394.0) $ (345.0) $ (317.0)
Amounts reclassified from accumulated other comprehensive income/(loss)   2.0 (1.0)   4.0 2.0            
Pension and other post-retirement adjustments   0.0 1.0   0.0 2.0            
Tax expense/(benefit)     1.0   0.0 (1.0)            
Accumulated Translation Adjustment [Member]                        
Subsequent Event                        
Other comprehensive income/(loss) before reclassifications   27.0 (22.0)   10.0 (54.0)            
Foreign currency translation adjustments     (22.0)   10.0 (54.0)            
Accumulated other comprehensive income/(loss)   (368.0) (322.0)   (368.0) (322.0)   (395.0)   (378.0) (300.0) (268.0)
Amounts reclassified from accumulated other comprehensive income/(loss)   0.0                    
AOCI, Derivative Qualifying as Hedge, Parent [Member]                        
Subsequent Event                        
Other comprehensive income/(loss) before reclassifications   (2.0) 17.0   12.0 21.0            
Accumulated other comprehensive income/(loss)   39.0 21.0   39.0 21.0   41.0   27.0 4.0  
Amounts reclassified from accumulated other comprehensive income/(loss)   0.0                    
ACOI, Accumulated Gain (Loss), Marketable Securities [Member]                        
Subsequent Event                        
Other comprehensive income/(loss) before reclassifications   0.0 (1.0) $ 0.0   (2.0)            
Net change in derivatives and hedges, net of tax   (2.0) 17.0   12.0 21.0            
Available for sale investments     (1.0)   4.0 (2.0)            
Accumulated other comprehensive income/(loss)   0.0 (3.0)   0.0 (3.0)   (2.0)   (4.0) (2.0) (1.0)
Amounts reclassified from accumulated other comprehensive income/(loss)   2.0     4.0              
Accumulated Defined Benefit Plans Adjustment [Member]                        
Subsequent Event                        
Other comprehensive income/(loss) before reclassifications   0.0                    
Accumulated other comprehensive income/(loss)   (38.0) (45.0)   (38.0) (45.0)   (38.0)   (38.0) (46.0) (47.0)
Amounts reclassified from accumulated other comprehensive income/(loss)   0.0 1.0     2.0            
Pension and other post-retirement adjustments   0.0 1.0   0.0 2.0            
Available-for-sale Securities [Member]                        
Subsequent Event                        
Other comprehensive income/(loss) before reclassifications   0.0                    
Other Comprehensive Income, Other, Net of Tax   0.0                    
Accumulated other comprehensive income/(loss)   (1.0) (1.0)   (1.0) (1.0)   $ (1.0)   (1.0) $ (1.0) $ (1.0)
Amounts reclassified from accumulated other comprehensive income/(loss)   0.0                    
PharmaConsumerHealth                        
Subsequent Event                        
Segment EBITDA   125.0 $ 144.0   368.0 $ 390.0            
Assets   $ 4,847.0     $ 4,847.0         $ 4,356.0    
Metrics                        
Subsequent Event                        
Business Combination, Consideration Transferred $ 474.0